By Mayo Clinic Staff

COVID-19 vaccines lower the risk of getting sick, seriously ill or dying from the disease. But how do the different types of COVID-19 vaccines work?

Each COVID-19 vaccine causes the immune system to create proteins called antibodies. These proteins fight infection with the COVID-19 virus. COVID-19 vaccines use a harmless version of a spikelike structure called an S protein on the surface of the COVID-19 virus.

There are a few main types of COVID-19 vaccines.

An mRNA vaccine gives cells instructions for how to make the S protein found on the surface of the COVID-19 virus.

The vaccine shot sends the mRNA into the muscle. Your muscle cells may take in the mRNA and make the S protein. Or the mRNA may be picked up by an immune cell. Either the mRNA or the S protein alerts the body to the risk of the virus. Then the body begins to create a response to prevent you from getting sick from the infection.c

In this type of vaccine, material from the virus that causes COVID-19 is placed in a modified version of a different virus. This different virus is called a viral vector. The viral vector gives cells instructions to make copies of the COVID-19 virus S protein.

Once the cells display the S proteins on their surfaces, the immune system responds by creating antibodies and defensive white blood cells. If infection with the virus that causes COVID-19 happens later, the antibodies help clear out the virus.

Viral vector vaccines can't cause infection with the COVID-19 virus or the viral vector virus. The Johnson & Johnson COVID-19 vaccine is a vector vaccine that's no longer used in the United States.

Subunit vaccines include only the parts of a virus that best stimulate the immune system. This type of COVID-19 vaccine has harmless S proteins in it. Once the immune system recognizes the S proteins, it creates antibodies and defensive white blood cells. If infection with the COVID-19 virus happens later, the antibodies help clear out the virus.

The Novavax COVID-19 vaccine is a protein subunit vaccine.

The 2026-2027 COVID-19 vaccines available in the United States include Moderna, Pfizer-BioNTech and Novavax. The vaccines are all approved for people age 65 and older. Each vaccine is also approved for younger people with a health condition that raises the risk of serious COVID-19 illness.

Moderna COVID-19 vaccine 2026-2027 formulas.

• Spikevax. This vaccine is approved for people age 6 months to 64 years with a risk of serious COVID-19 illness and all people age 65 and older.
• Mnexspike. This vaccine is approved for people age 12 to 64 years with a risk of serious COVID-19 illness and all people age 65 and older.

Pfizer BioNTech COVID-19 vaccine 2026-2027 formula.

• Comirnaty. This vaccine is approved for people age 5 to 64 years with a risk of serious COVID-19 illness and all people age 65 and older.

Novavax COVID-19 vaccine 2026-2027 formula.

• Nuvaxovid. This vaccine is approved for people age 12 to 64 years with a risk of serious COVID-19 illness and all people age 65 and older.

The COVID-19 vaccines for 2026-2027 focus on building protection against the JN.1 virus strain called XFG.

Who should get a COVID-19 vaccine?

Getting a COVID-19 vaccine protects against serious illness, the need for hospital care due to COVID-19 and death from COVID-19. Staying up to date with the latest vaccine is most important for people at higher risk. That includes adults over age 65, those with weakened immune systems, people who are pregnant, and people with chronic conditions, such as heart disease, lung disease or obesity.